Home SEC Filings Minerva Neurosciences, Inc. (NASDAQ:NERV) Files An 8-K Entry into a Material …

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of a …

Link to Full Article

Pin It on Pinterest

Share This